Re: 5α-Reductase Inhibitors and the Risk of Cancer-Related Mortality in Men with Prostate Cancer

被引：0
|
作者：
Kaplan, Steven A.
机构：
来源：
JOURNAL OF UROLOGY | 2016年 / 196卷 / 05期
关键词：
D O I：
10.1016/j.juro.2016.08.044
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1506 / 1506
页数：1
相关论文
共 50 条
  • [1] 5α-Reductase Inhibitors and the Risk of Cancer-Related Mortality in Men With Prostate Cancer
    Azoulay, Laurent
    Eberg, Maria
    Benayoun, Serge
    Pollak, Michael
    [J]. JAMA ONCOLOGY, 2015, 1 (03) : 314 - 320
  • [2] Prostate cancer-related mortality risk assessment in a cohort of southern Nigerian men
    Okoye, Jude O.
    Ogbonnaya, Vivian I.
    Emeka, Chiemeka M.
    Obioma, Okechi
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [3] 5-α Reductase Inhibitors and Prostate Cancer Mortality
    Hamilton, Robert J.
    Chavarriaga, Julian
    Khurram, Najia
    Lau, Cindy
    Luo, Jin
    Liu, Ning
    Komisarenko, Maria
    Kulkarni, Girish
    Wallis, Christopher
    Juurlink, David N.
    Fleshner, Neil
    Finelli, Antonio
    [J]. JAMA NETWORK OPEN, 2024, 7 (08)
  • [4] Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality
    Bjornebo, Lars
    Nordstrom, Tobias
    Discacciati, Andrea
    Palsdottir, Thorgerdur
    Aly, Markus
    Gronberg, Henrik
    Eklund, Martin
    Lantz, Anna
    [J]. JAMA ONCOLOGY, 2022, 8 (07) : 1019 - 1026
  • [5] Re: Association of Treatment with 5α-Reductase inhibitors with Time to Diagnosis and Mortality in Prostate Cancer
    Walsh, Patrick C.
    [J]. EUROPEAN UROLOGY, 2019, 76 (05) : 704 - 704
  • [6] Re: Association of Treatment with 5α-Reductase Inhibitors with Time to Diagnosis and Mortality in Prostate Cancer
    Taneja, Samir S.
    [J]. JOURNAL OF UROLOGY, 2019, 202 (05): : 2 - 4
  • [7] 5-ALPHA REDUCTASE INHIBITORS AND THE RISK OF PROSTATE CANCER MORTALITY IN MEN TREATED FOR BENIGN PROSTATIC HYPERPLASIA
    Wallner, Lauren
    DiBello, Julia
    Li, Bonnie
    Van Den Eeden, Stephen
    Weinmann, Sheila
    Ritzwoller, Debra
    Abell, Jill
    D'Agostino, Ralph, Jr.
    Loo, Ronald
    Aaronson, David
    Richert-Boe, Kathryn
    Horwitz, Ralph
    Jacobsen, Steven
    [J]. JOURNAL OF UROLOGY, 2016, 195 (04): : E27 - E28
  • [8] 5-Alpha Reductase Inhibitors and the Risk of Prostate Cancer Mortality in Men Treated for Benign Prostatic Hyperplasia
    Wallner, Lauren P.
    DiBello, Julia R.
    Li, Bonnie H.
    Van Den Eeden, Stephen K.
    Weinmann, Sheila
    Ritzwoller, Debra P.
    Abell, Jill E.
    D'Agostino, Ralph, Jr.
    Loo, Ronald K.
    Aaronson, David S.
    Richert-Boe, Kathryn
    Horwitz, Ralph I.
    Jacobsen, Steven J.
    [J]. MAYO CLINIC PROCEEDINGS, 2016, 91 (12) : 1717 - 1726
  • [9] 5α-Reductase Inhibitors and Risk of Prostate Cancer Death
    Miranda, Tiago Bonde
    Garmo, Hans
    Stattin, Par
    Robinson, David
    [J]. JOURNAL OF UROLOGY, 2020, 204 (04): : 714 - 719
  • [10] Revisiting 5α-reductase inhibitors and the risk of prostate cancer
    Chau, Cindy H.
    Figg, William D.
    [J]. NATURE REVIEWS UROLOGY, 2018, 15 (07) : 400 - 401
12345